Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

Bergenstal, Richard M, Dr ; Wysham, Carol, MD ; MacConell, Leigh, PhD ; Malloy, Jaret, PhD ; Walsh, Brandon, PhD ; Yan, Ping, PhD ; Wilhelm, Ken, MD ; Malone, Jim, MD ; Porter, Lisa E, MD

The Lancet (British edition), 2010-08, Vol.376 (9739), p.431-439 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível